1-4 of 4
A. Candoni, MD
Close
Sort by
Journal Articles

Anagrelide Treatment and Cardiovascular Evaluation in 130 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia (RIT).

Luigi Gugliotta, MD, A. Tieghi, MD, S. Bulgarelli, MD, G. Tortorella, MD, R. Ciancia, MD, P. R. Scalzulli, MD, E. Cacciola, MD, R. Cacciola, MD, D. Rossi, MD, E. Usala, MD, M. Crugnola, MD, A. Candoni, MD, M. Giordano, MD, A. Andriani, MD, C. Santoro, MD, R. Vimercati, MD, M. Liberati, MD, A. Sciorio, MD, G. Specchia, MD, V. Martinelli, MD, G. Gaidano, MD, M. G. Mazzucconi, MD
Journal: Blood
Blood (2005) 106 (11): 4956.
https://doi.org/10.1182/blood.V106.11.4956.4956
Published: 2005
Journal Articles

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, M. Vignetti, MD, A. Cupri, MD, M. Sborgia, MD, D. Vincelli, MD, A. Candoni, MD, F. Salvi, MD, S. Rupoli, MD, G. Martinelli, MD, M.G. Kropp, MD, N. Di Rienzo, MD, V. Zampaglione, MD, A. Venditti, PhD, L. Melillo, MD, G. Cimino, PhD, M.C. Petti, MD, G. Avvisati, PhD, F. Lo Coco, PhD, F. Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 885.
https://doi.org/10.1182/blood.V106.11.885.885
Published: 2005
Journal Articles

Bone Marrow Evaluation According to the PVSG and WHO Criteria in 90 Essential Thrombocythemia (ET) Patients Treated with PEG Interferon alpha-2b. Preliminary Results.

Luigi Gugliotta, MD, S. Bulgarelli, MD, S. Asioli, MD, A. Tieghi, MD, G. Gardini, MD, E. Sabattini, MD, V. Franco, MD, E. Boveri, MD, H. M. Kvasnicka, MD, N. Vianelli, MD, A. Candoni, MD, R. Latagliata, MD, F. Passamonti, MD, S. Rupoli, MD, V. Martinelli, MD, A. Zaccaria, MD, F. Lauria, MD, E. De Biasi, MD, S. Sacchi, MD, M. Gobbi, MD, A. Tabilio, MD, E. Cacciola, MD, R. Cacciola, MD, A. Grossi, MD, P. Mazza, MD, F. Bonifazi, MD, P. Favini, F. Mandelli, MD, M. Baccarani, MD, J. Thiele, MD
Journal: Blood
Blood (2005) 106 (11): 4962.
https://doi.org/10.1182/blood.V106.11.4962.4962
Published: 2005
Journal Articles

PEG Intron Treatment in 90 Patients with Essential Thrombocythemia (ET) Final Report of a Phase II Study.

Luigi Gugliotta, MD, S. Bulgarelli, MD, N. Vianelli, MD, D. Russo, MD, A. Candoni, MD, S. Rupoli, MD, R. Latagliata, MD, S. Sacchi, MD, V. Martinelli, MD, E. De Biasi, MD, A. Bucalossi, MD, S. Mazzotta, MD, A. Tabilio, MD, F. Passamonti, MD, A. Grossi, MD, E. Cacciola, MD, R. Cacciola, MD, E. Pogliani, MD, F. Bonifazi, MD, R. Fanin, MD, P. Leoni, MD, F. Mandelli, MD, A. Zaccaria, MD, F. Lauria, MD, M. Lazzarino, MD, M. Gobbi, MD, A. Bosi, MD, P. Mazza, MD, G. Fincato, MD, P. Favini, MD, M. Baccarani, MD
Journal: Blood
Blood (2005) 106 (11): 2600.
https://doi.org/10.1182/blood.V106.11.2600.2600
Published: 2005